Home › Leukemia › Minnesota › Minneapolis
Leukemia clinical trials in Minneapolis, MN
4 studies for Leukemia are looking for participants at sites in and around Minneapolis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
RecruitingPhase 3
- University of Minnesota, Minneapolis
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
RecruitingObservational study
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
RecruitingPhase 2
- Children's Hospitals and Clinics of Minnesota, Minneapolis
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
RecruitingPhase 1
- University of Minnesota, Minneapolis
About Leukemia
Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.
More about Leukemia on MedlinePlus
Leukemia trials in other cities
- Houston, TX31 studies
- Boston, MA27 studies
- New York City, NY21 studies
- Chicago, IL19 studies
- Los Angeles, CA17 studies
- Durham, NC14 studies
- Baldwin Park, CA14 studies
- Nashville, TN13 studies
- Columbus, OH13 studies
- Philadelphia, PA13 studies
- Atlanta, GA12 studies
- Milwaukee, WI12 studies
Other studies in Minneapolis
- Non-Small Cell Lung Cancer29 studies
- Breast Cancer23 studies
- Ovarian Cancer23 studies
- Prostate Cancer22 studies
- Heart Failure22 studies
- Cancer (all types)21 studies
- Endometrial Cancer20 studies
- Colorectal Cancer20 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia19 studies
- Parkinson's Disease17 studies
- Coronary Artery Disease15 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.